Caldwell Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Caldwell Trust’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$177K	–	738
2022 Q3	$177K	Hold	4,000	–	–	0.03%	287
2022 Q2	$148K	Hold	4,000	–	–	0.02%	314
2022 Q1	$148K	Hold	4,000	–	–	0.02%	316
2021 Q4	$122K	Hold	4,000	–	–	0.01%	348
2021 Q3	$134K	Hold	4,000	–	–	0.02%	326
2021 Q2	$160K	Hold	4,000	–	–	0.02%	305
2021 Q1	$180K	Hold	4,000	–	–	0.03%	286
2020 Q4	$226K	Hold	4,000	–	–	0.03%	239
2020 Q3	$190K	Hold	4,000	–	–	0.03%	246
2020 Q2	$236K	Hold	4,000	–	–	0.04%	228
2020 Q1	$189K	Hold	4,000	–	–	0.04%	244
2019 Q4	$242K	Buy	+4,000	New	+$238K	0.04%	246

Other funds holding IONS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return